<div id="readability-page-1"><div><p><span>Esperion Therapeutics Inc </span><span>:</span></p><ul><li>ESPERION’S BEMPEDOIC ACID RECEIVES LEVEL 1A RECOMMENDATION IN UPDATED ESC/EAS GUIDELINES FOR MANAGEMENT OF DYSLIPIDAEMIAS</li><li>ESPERION THERAPEUTICS INC - BEMPEDOIC ACID RECOMMENDED FOR PATIENTS UNABLE TO TAKE STATIN THERAPY TO ACHIEVE LDL-C GOAL. CLASS I, LEVEL B</li></ul></div></div>

ESPR

<p>Esperion Therapeutics Inc :ESPERION’S BEMPEDOIC ACID RECEIVES LEVEL 1A RECOMMENDATION IN UPDATED ESC/EAS GUIDELINES FOR MANAGEMENT OF DYSLIPIDAEMIASESPERION THERAPEUTICS INC - BEMPEDOIC ACID RECOMMENDED FOR PATIENTS UNABLE TO TAKE STATIN THERAPY TO ACHIEVE LDL-C GOAL. CLASS I, LEVEL B</p>

Esperion 的 Bempedoic Acid 在最新的 ESC/EAS 血脂异常管理指南中获得了 1a 级推荐